MYC Regulation of Cell Growth through Control of Transcription by RNA Polymerases I and III

Por Campbell, Kirsteen J., White, Robert J.
Publicado em 2014

Targeting BCL-2 regulated apoptosis in cancer

Por Campbell, Kirsteen J., Tait, Stephen W. G.
Publicado no Open Biol (2018)

Differential regulation of NF-κB activation and function by topoisomerase II inhibitors

Por Campbell, Kirsteen J, O'Shea, John M, Perkins, Neil D
Publicado em 2006

The p53-inhibitor Pifithrin-α inhibits Firefly Luciferase activity in vivo and in vitro

Por Rocha, Sonia, Campbell, Kirsteen J, Roche, Kevin C, Perkins, Neil D
Publicado em 2003

Regulation of NF-κB and p53 through activation of ATR and Chk1 by the ARF tumour suppressor

Por Rocha, Sonia, Garrett, Michelle D, Campbell, Kirsteen J, Schumm, Katie, Perkins, Neil D
Publicado em 2005

Mnt modulates Myc-driven lymphomagenesis

Por Campbell, Kirsteen J, Vandenberg, Cassandra J, Anstee, Natasha S, Hurlin, Peter J, Cory, Suzanne
Publicado no Cell Death Differ (2017)

Cezanne regulates E2F1-dependent HIF2α expression

Por Moniz, Sonia, Bandarra, Daniel, Biddlestone, John, Campbell, Kirsteen J., Komander, David, Bremm, Anja, Rocha, Sonia
Publicado no J Cell Sci (2015)

Overexpression of Mcl-1 exacerbates lymphocyte accumulation and autoimmune kidney disease in lpr mice

Por Anstee, Natasha S, Vandenberg, Cassandra J, Campbell, Kirsteen J, Hughes, Peter D, O'Reilly, Lorraine A, Cory, Suzanne
Publicado no Cell Death Differ (2017)

Elevated Mcl-1 perturbs lymphopoiesis, promotes transformation of hematopoietic stem/progenitor cells, and enhances drug resistance

Por Campbell, Kirsteen J., Bath, Mary L., Turner, Marian L., Vandenberg, Cassandra J., Bouillet, Philippe, Metcalf, Donald, Scott, Clare L., Cory, Suzanne
Publicado em 2010

MCL-1 is a prognostic indicator and drug target in breast cancer

Por Campbell, Kirsteen J., Dhayade, Sandeep, Ferrari, Nicola, Sims, Andrew H., Johnson, Emma, Mason, Susan M., Dickson, Ashley, Ryan, Kevin M., Kalna, Gabriela, Edwards, Joanne, Tait, Stephen W. G., Blyth, Karen
Publicado no Cell Death Dis (2018)

Brf1 loss and not overexpression disrupts tissues homeostasis in the intestine, liver and pancreas

Por Liko, Dritan, Mitchell, Louise, Campbell, Kirsteen J., Ridgway, Rachel A., Jones, Carolyn, Dudek, Kate, King, Ayala, Bryson, Sheila, Stevenson, David, Blyth, Karen, Strathdee, Douglas, Morton, Jennifer P., Bird, Thomas G., Knight, John R. P., Willis, Anne E., Sansom, Owen J.
Publicado no Cell Death Differ (2019)

Condensin II mutation causes T-cell lymphoma through tissue-specific genome instability

Por Woodward, Jessica, Taylor, Gillian C., Soares, Dinesh C., Boyle, Shelagh, Sie, Daoud, Read, David, Chathoth, Keerthi, Vukovic, Milica, Tarrats, Nuria, Jamieson, David, Campbell, Kirsteen J., Blyth, Karen, Acosta, Juan Carlos, Ylstra, Bauke, Arends, Mark J., Kranc, Kamil R., Jackson, Andrew P., Bickmore, Wendy A., Wood, Andrew J.
Publicado no Genes Dev (2016)

Fas-mediated neutrophil apoptosis is accelerated by Bid, Bak, and Bax and inhibited by Bcl-2 and Mcl-1

Por Croker, Ben A., O'Donnell, Joanne A., Nowell, Cameron J., Metcalf, Donald, Dewson, Grant, Campbell, Kirsteen J., Rogers, Kelly L., Hu, Yifang, Smyth, Gordon K., Zhang, Jian-Guo, White, Michael, Lackovic, Kurt, Cengia, Louise H., O'Reilly, Lorraine A., Bouillet, Philippe, Cory, Suzanne, Strasser, Andreas, Roberts, Andrew W.
Publicado em 2011

Bcl-2, Bcl-x(L), and Bcl-w are not equivalent targets of ABT-737 and navitoclax (ABT-263) in lymphoid and leukemic cells

Por Mérino, Delphine, Khaw, Seong L., Glaser, Stefan P., Anderson, Daniel J., Belmont, Lisa D., Wong, Chihunt, Yue, Peng, Robati, Mikara, Phipson, Belinda, Fairlie, Walter D., Lee, Erinna F., Campbell, Kirsteen J., Vandenberg, Cassandra J., Cory, Suzanne, Roberts, Andrew W., Ludlam, Mary J. C., Huang, David C. S., Bouillet, Philippe
Publicado em 2012

BRF1 accelerates prostate tumourigenesis and perturbs immune infiltration

Por Loveridge, Carolyn J., Slater, Sarah, Campbell, Kirsteen J., Nam, Noor A., Knight, John, Ahmad, Imran, Hedley, Ann, Lilla, Sergio, Repiscak, Peter, Patel, Rachana, Salji, Mark, Fleming, Janis, Mitchell, Louise, Nixon, Colin, Strathdee, Douglas, Neilson, Matthew, Ntala, Chara, Bryson, Sheila, Zanivan, Sara, Edwards, Joanne, Robson, Craig N., Goodyear, Carl S., Blyth, Karen, Leung, Hing Y.
Publicado no Oncogene (2019)

Correction: BRF1 accelerates prostate tumourigenesis and perturbs immune infiltration

Por Loveridge, Carolyn J., Slater, Sarah, Campbell, Kirsteen J., Nam, Noor A., Knight, John, Ahmad, Imran, Hedley, Ann, Lilla, Sergio, Repiscak, Peter, Patel, Rachana, Salji, Mark, Fleming, Janis, Mitchell, Louise, Nixon, Colin, Strathdee, Douglas, Neilson, Matthew, Ntala, Chara, Bryson, Sheila, Zanivan, Sara, Edwards, Joanne, Robson, Craig N., Goodyear, Carl S., Blyth, Karen, Leung, Hing Y.
Publicado no Oncogene (2019)